Recently, it was reported that chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence [38], so it is possible to explain these evidences also in consideration of the deregulated S100 expression. The gene discussed is S100B; the disease is breast cancer.